Wetzel Investment Advisors, Inc. Cidara Therapeutics, Inc. Transaction History

Wetzel Investment Advisors, Inc.

  • $174 Million
  • Q2 2024

A detailed history of Wetzel Investment Advisors, Inc. transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 4,000 shares of CDTX stock, worth $43,600. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,000 -0.0%
Holding current value
$43,600
Previous $3,000 1466.67%
% of portfolio
0.03%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024
BUY
$0.68 - $0.97 $2,720 - $3,880
4,000 New
4,000 $3,000

Others Institutions Holding CDTX

# of Institutions
1
Shares Held
4K
Call Options Held
0
Put Options Held
0
View Full List

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $764M
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Wetzel Investment Advisors, Inc. Portfolio

Follow Wetzel Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetzel Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wetzel Investment Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email